Abstract
We present the case of a young man who received a left ventricular assist device (LVAD) as a bridge to transplantation for end-stage heart failure, in whom the diagnosis of sarcoid cardiomyopathy was made at the time of LVAD implantation. He subsequently underwent uncomplicated heart transplantation. Nineteen months later, a routine surveillance endomyocardial biopsy specimen demonstrated recurrence of sarcoidosis in the transplanted heart.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents / therapeutic use
-
Cardiomyopathies / diagnosis
-
Cardiomyopathies / drug therapy
-
Cardiomyopathies / pathology
-
Cardiomyopathies / surgery*
-
Heart Transplantation*
-
Heart Ventricles / pathology
-
Heart-Assist Devices
-
Humans
-
Male
-
Myocardium / pathology
-
Postoperative Complications / etiology*
-
Postoperative Period
-
Prednisone / therapeutic use
-
Recurrence
-
Sarcoidosis / diagnosis
-
Sarcoidosis / drug therapy
-
Sarcoidosis / pathology
-
Sarcoidosis / surgery*
Substances
-
Anti-Inflammatory Agents
-
Prednisone